Projects per year
Personal profile
Education
- Ph.D. (Toxicology), National Taiwan University
Research Interests
- Drugs Development of Antimucositis and Anticancer.
- Drugs Development of Retinopathy and Age-Relative Macular Degeneration Diseases.
- Toxicity testing for food, drugs and cosmetics.
Fingerprint Dive into the research topics where Yu-Wen Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Rats
Chemical Compounds
Aryl Hydrocarbon Receptors
Medicine & Life Sciences
Chemical activation
Chemical Compounds
Endothelial cells
Chemical Compounds
Vasodilation
Medicine & Life Sciences
Human Umbilical Vein Endothelial Cells
Medicine & Life Sciences
Cells
Chemical Compounds
Sarcoplasmic Reticulum
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2013 2020
探討一氧化氮奈米載體釋放系統應用於眼腦血管與神經相關之藥理作用機轉與潛在生物效應-探討一氧化氮奈米載體釋放系統於藍光誘發之視網膜病變及相關的藥理或生物效應(3/3)
8/1/19 → 7/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
探討苯乙醇苷衍生物對於藍光與氧化性物質視黃醛引起視網膜退化之藥理作用機制與視網膜病變之保護療效評估(3/3)
8/1/19 → 7/1/20
Project: A - Government Institution › b - Ministry of Science and Technology
探討Aroylindoline衍生物類小分子藥物應用於眼腦血管與神經相關之視網膜病變-Aroylindoline derivatives類小分子應用藍光誘發之眼腦相關視網膜病變治療機轉
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
探討一氧化氮奈米載體釋放系統應用於眼腦血管與神經相關之藥理作用機轉與潛在生物效應-探討一氧化氮奈米載體釋放系統於藍光誘發之視網膜病變及相關的藥理或生物效應(2/3)
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
探討苯乙醇苷衍生物對於藍光與氧化性物質視黃醛引起視網膜退化之藥理作用機制與視網膜病變之保護療效評估(2/3)
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output 1996 2020
Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCα-mediated AHR-HDAC interactions
Tsai, C. H., Li, C. H., Liao, P. L., Chang, Y. W., Cheng, Y. W. & Kang, J. J., Feb 2020, In : Biochimica et Biophysica Acta - Molecular Cell Research. 1867, 2, 118564.Research output: Contribution to journal › Article
Aryl Hydrocarbon Receptors
Histone Deacetylase Inhibitors
Histone Deacetylases
Stomach Neoplasms
Cell Movement
3
Citations
(Scopus)
Chloramphenicol induces autophagy and inhibits the hypoxia inducible factor-1 alpha pathway in non-small cell lung cancer cells
Hsu, H. L., Liao, P. L., Cheng, Y. W., Huang, S. H., Wu, C. H., Li, C. H. & Kang, J. J., Jan 1 2019, In : International Journal of Molecular Sciences. 20, 1, 157.Research output: Contribution to journal › Article
Hypoxia-Inducible Factor 1
hypoxia
Autophagy
Chloramphenicol
Non-Small Cell Lung Carcinoma
Correction to: Inhaled gold nanoparticles cause cerebral edema and upregulate endothelial aquaporin 1 expression, involving caveolin 1 dependent repression of extracellular regulated protein kinase activity (Particle and Fibre Toxicology (2019) 16 (37) DOI: 10.1186/s12989-019-0324-2)
Chen, C. Y., Liao, P. L., Tsai, C. H., Chan, Y. J., Cheng, Y. W., Hwang, L. L., Lin, K. H., Yen, T. L. & Li, C. H., Nov 18 2019, In : Particle and Fibre Toxicology. 16, 1, 43.Research output: Contribution to journal › Comment/debate
Open Access
Aquaporin 1
Caveolin 1
Brain Edema
Gold
Nanoparticles
Down-regulation of aryl hydrocarbon receptor intensifies carcinogen-induced retinal lesion via SOCS3-STAT3 signaling
Tsai, C. H., Lee, Y., Li, C. H., Cheng, Y. W. & Kang, J. J., Jan 1 2019, (Accepted/In press) In : Cell Biology and Toxicology.Research output: Contribution to journal › Article
Aryl Hydrocarbon Receptors
STAT3 Transcription Factor
Carcinogens
Down-Regulation
Cytokines
Efficacy of azatyrosine-phenylbutyric hydroxamides, a histone deacetylase inhibitor, on chemotherapy-induced gastrointestinal mucositis
Liao, P. L., Huang, S. H., Hung, C. H., Huang, W. K., Tsai, C. H., Kang, J. J., Wang, H. P. & Cheng, Y. W., Jan 1 2019, In : International Journal of Molecular Sciences. 20, 2, 249.Research output: Contribution to journal › Article
monocytes
interleukins
Mucositis
Histone Deacetylase Inhibitors
Chemotherapy